XML 63 R50.htm IDEA: XBRL DOCUMENT v3.24.4
Net Earnings (Loss) per Share (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Loss per common share:    
Schedule of Basic and Diluted Net Loss per Share Attributable to Common Stockholders

The following table sets forth the computation of the Company’s basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share data):

 

                 
   Three Months Ended   Nine Months Ended 
   September 30,   September 30, 
   2024   2023   2024   2023 
Net loss  $(5,669)  $(6,342)  $(16,363)  $(23,657)
Weighted average common shares outstanding, basic and diluted   5,773,993    1,366,842    4,833,091    1,346,264 
Net loss per share, basic and diluted  $(0.98)  $(4.64)  $(3.39)  $(17.57)

The following table sets forth the computation of the Company’s basic and diluted net earnings (loss) per share attributable to common stockholders (in thousands, except share and per share data):

 

   2023   2022 
   For years ended December 31, 
   2023   2022 
Net loss  $(20,131)  $(640)
Weighted average common shares outstanding, basic and diluted   1,546,297    1,056,988 
Net loss per share, basic and diluted  $(13.02)  $(0.61)
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings per Share

The following table sets forth the securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future:

 

September 30,  2024   2023 
Common stock warrants   2,269,356    459,856 
Common stock options and RSUs   1,775,444    82,719 
Unit Purchase Options   20,182    20,812 
Shares related to Series B-2 convertible preferred stock   6,636,981    - 
Shares related to Series B-3 convertible preferred stock   10,026,859    - 
Total   20,728,822    563,387 

The following table sets forth securities that were anti-dilutive for diluted EPS for the periods presented but which could potentially dilute EPS in the future:

 

December 31,  2023   2022 
Common stock warrants   2,269,356    459,856 
Common stock options and RSUs   104,257    104,127 
Unit Purchase Options   20,182    20,182 
Total   2,393,795    584,165